Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lidia Perrone"'
Autor:
Giovanni Scambia, Lidia Perrone, Gabriella Ferrandina, Salvatore Mancuso, Stefano Iacobelli, Pierluigi Benedetti Panici, Clara Natoli, G. Baiocchi, Francesco Battaglia, Carla Sonsini
Publikováno v:
Cancer. 65:1325-1328
The circulating levels of a 90-kilodalton (K) tumor-associated antigen were measured in the blood of 43 patients with gynecologic and breast malignancies who underwent a short course of recombinant alpha-2b-interferon (rIFN alpha-2b) (3 million U/m2/
Autor:
Stefano Greggi, Giovanni Scambia, Lidia Perrone, Salvatore Mancuso, P. Benedetti Panici, G. Baiocchi
Publikováno v:
Gynecologic Oncology. 30:265-273
Serum levels of CA 15-3 were measured in 778 samples from 270 patients with benign and malignant gynecological conditions. Malignant tumors were present in 180 patients including 58 cases with cancer of the ovary, 47 of the endometrium, 61 of the cer
Autor:
Kiyotaka Umaki, Jorma Mattila, V.G. Pahnke, G. Baiocchi, Kjell Carlström, Uzi Dan, T.C. Schlotfeldt, Salvatore Mancuso, Ken Makihara, Mordechai Goldenberg, Shinnosuke Kawagoe, Osamu Takamiya, Giuseppe Rizzo, Hanno Ulmer, K. Seki, Toshiyuki Hata, Lidia Perrone, Reijo Punnonen, Marcos Felipe Silva de Sá, Gad Barkai, Roberto Salles Meirelles, Stefano Greggi, Ehud Kukkia, Timo Koivula, Shlomo Mashiach, Carlo Romanini, Pierluigi Benedetti Panici, Daisaku Senoh, Helmut Pschera, Anders Hjerpe, G.A. Everett, Domenico Arduini, Francesco Battaglia, F. Bode, Showa Aoki, J. Apgar, Giovanni Scambia, E. Goepel, Kohkichi Hata, Masahiko Hiroi, Manabu Kitao, Bidder David, Olli-Pekka Kallioniemi
Publikováno v:
Gynecologic and Obstetric Investigation. 27:I-IV
Autor:
Clara Natoli, Salvatore Mancuso, Lidia Perrone, Giovanni Scambia, P B Panici, Stefano Iacobelli, G. Baiocchi
Publikováno v:
International Journal of Cancer. 42:182-184
We have previously reported the production of a new monoclonal antibody (MAb) (SP-2) recognizing a 90-kDa tumor-associated antigen, termed 90K, which is increased in the serum of many cancer patients. Treatment of CG5 human breast cancer cells with r